As of 2025-04-19, the Intrinsic Value of Cresco Labs Inc (CL.CN) is 2.32 CAD. This CL.CN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.89 CAD, the upside of Cresco Labs Inc is 160.50%.
The range of the Intrinsic Value is 0.72 - 12.96 CAD
Based on its market price of 0.89 CAD and our intrinsic valuation, Cresco Labs Inc (CL.CN) is undervalued by 160.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 0.72 - 12.96 | 2.32 | 160.5% |
| DCF (Growth 10y) | 1.16 - 15.08 | 3.01 | 238.1% |
| DCF (EBITDA 5y) | 2.30 - 6.61 | 4.07 | 356.8% |
| DCF (EBITDA 10y) | 2.25 - 7.79 | 4.33 | 386.3% |
| Fair Value | -1.16 - -1.16 | -1.16 | -230.59% |
| P/E | (3.79) - 0.38 | (1.87) | -309.6% |
| EV/EBITDA | 1.45 - 4.77 | 3.25 | 265.2% |
| EPV | (0.25) - 1.09 | 0.42 | -52.8% |
| DDM - Stable | (2.51) - (13.35) | (7.93) | -990.9% |
| DDM - Multi | 1.42 - 6.09 | 2.33 | 161.8% |
| Market Cap (mil) | 394.70 |
| Beta | 2.18 |
| Outstanding shares (mil) | 443.48 |
| Enterprise Value (mil) | 1,090.03 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.03% |
| Cost of Debt | 14.47% |
| WACC | 9.85% |